AOX Launches an Equity Crowdfunding Round to Raise 688,000 Euros

AOX Cosmeceuticals is an innovative startup founded in 2023 thanks to the experience of Luigi Alfani, a pharmacist for four generations and entrepreneur.

The company has designed and patented, in collaboration with the University of Oviedo, the Deep Delivery System®, a technology capable of transporting numerous anti-aging active ingredients through the skin.

The equity crowdfunding campaign, just launched on Mamacrowd, has the goal of raising up to 688,000 euros. Moreover, the minimum goal of 150,000 euros has already been largely exceeded thanks to the 583 euros already raised.

AOX Technology

The active ingredients are encapsulated in natural microspheres capable of passing through the skin and subsequently releasing them, guaranteeing up to + 1,100% penetration compared to the free form and up to + 90% collagen recovered in just 11 days of treatment.

In addition, AOX has developed a skin analysis system based on artificial intelligence that allows simulating future skin development and therefore identifying the most suitable products.

AOX products are also developed with green formulas without parabens, SLS, petrolatum and gluten and the packaging is made with FSC and recycled paper, for responsible forest management.

AOX is part of “1% FOR THE PLANET” an international organization whose members contribute at least 1% of their annual income to environmental causes to protect the environment.

The results already achieved by AOX

In the first year of direct distribution, the company opened over 110 new doors in Italy and estimates a 70% growth in turnover for 2024.

In 2023, the cosmetics market in Italy reached 12.5 billion euros (+8.9% vs. 2022). Pharmacy is now the third distribution channel, with a growth of 7.4% and a value of 2.1 billion euros.

The global cosmetics industry is experiencing great momentum, with a current value of 427 billion. This value is expected to increase by 6% annually, reaching 580 billion in 2027.

The AOX project was conceived from the beginning for a rapid internationalization of the brand.

Luigi Alfani, CEO and Founder of AOX , explained: “With a long experience in the pharmaceutical and cosmetic sector, together with colleagues from the University of Oviedo we have created something new and capable of innovating this sector. Italian production, the study of an airless system that preserves the products and the technology to support the analysis are our distinctive characteristics.”

__

(Featured image by AdoreBeautyNZ via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us